Evotec SE Share Price
NASDAQ: EVOEvotec SE Stock Performance
Evotec SE Share Price Today
As of 9 October 2026, Evotec SE's share price is $1.61. The stock opened at $1.61, compared to its previous close of $1.63. During today's trading session, Evotec SE's share price traded between $1.61 and $1.63, with an average price of $1.62. Over the past 52 weeks, the stock has recorded a high of $4.21 and a low of $1.50. In terms of performance, Evotec SE's share price has declined by 48.06% over the last six months and is down 60.15% on a year-on-year basis.
Evotec SE Share Price Chart
Evotec SE Annual Profit & Loss
All figures in USD
About Evotec SE
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Evotec SE Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.65 | $1.62 | -5.26% |
Sep 2026 | $1.81 | $1.71 | -12.31% |
Aug 2026 | $1.96 | $1.95 | +1.04% |
Jul 2026 | $2.89 | $1.93 | -31.07% |
Jun 2026 | $3.07 | $2.80 | -8.79% |
May 2026 | $3.11 | $3.07 | -0.97% |
Apr 2026 | $2.57 | $3.10 | +24.50% |
Mar 2026 | $3.30 | $2.49 | -26.98% |
Feb 2026 | $3.53 | $3.41 | -6.83% |
Jan 2026 | $3.20 | $3.66 | +16.56% |
Dec 2025 | $3.21 | $3.14 | -4.99% |
Nov 2025 | $4.05 | $3.31 | -18.19% |